Clinical Trial Update: A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating NovoTTF-200M and NovoTTF-200A systems for refractory spinal metastasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Metastasis

Drugs mentioned

• NOVOTTF-200A
• NovoTTF-200M

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Spinal Metastasis | Phase 1 | Status: RECRUITING